Literature DB >> 10362638

Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide.

R F Lodato1, A R Khan, M J Zembowicz, N W Weisbrodt, T A Pressley, Y F Li, J A Lodato, A Zembowicz, F G Moody.   

Abstract

Gastrointestinal stasis during sepsis may be associated with gastrointestinal smooth muscle dysfunction. Endotoxin [lipopolysaccharide (LPS)] impairs smooth muscle contraction, in part through inducible nitric oxide synthase (NOS II) and enhanced nitric oxide production. We studied the roles of tumor necrosis factor-alpha (TNF) and interleukin-1 (IL-1) in this process by using TNF binding protein (TNFbp) and IL-1 receptor antagonist (IL-1ra). Rats were treated with TNFbp and IL-1ra, or their vehicles, 1 h before receiving LPS or saline. At 5 h after LPS, contractility was measured in strips of ileal longitudinal smooth muscle, and NOS II activity was measured in full-thickness segments of ileum. LPS decreased maximum stress (mean +/- SE) from 508 +/- 55 (control) to 355 +/- 33 g/cm2 (P < 0.05). Pretreatment with TNFbp plus IL-1ra prevented the LPS-induced decrease. Separate studies of TNFbp alone or IL-1ra alone indicated that, at the doses and timing used, TNFbp was more effective. LPS also increased NOS II activity by >10-fold (P < 0.01) over control. This increase was prevented by TNFbp plus IL-1ra (P = not significant vs. control). We conclude that the LPS-induced increase in NOS II activity and the decrease in ileal muscle contractility are mediated by TNF and IL-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362638     DOI: 10.1152/ajpgi.1999.276.6.G1356

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

Review 1.  Small bowel review: Normal physiology, part 2.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

Review 2.  Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis.

Authors:  B M Buchholz; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-03       Impact factor: 3.598

3.  Brain or gut? Site of action of adrenomedullin to regulate gut motility.

Authors:  Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

4.  Aerobic exercise affects C57BL/6 murine intestinal contractile function.

Authors:  Claudio Andre Barbosa de Lira; Rodrigo Luiz Vancini; Silvia Saiuli Miki Ihara; Antonio Carlos da Silva; Jeannine Aboulafia; Viviane Louise Andree Nouailhetas
Journal:  Eur J Appl Physiol       Date:  2008-02-14       Impact factor: 3.078

5.  Pretreatment with adenosine and adenosine A1 receptor agonist protects against intestinal ischemia-reperfusion injury in rat.

Authors:  V Haktan Ozacmak; Hale Sayan
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

6.  Magnolol pretreatment prevents sepsis-induced intestinal dysmotility by maintaining functional interstitial cells of Cajal.

Authors:  Bin Miao; Shuwen Zhang; Hong Wang; Tiecheng Yang; Deshan Zhou; Bao-en Wang
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  Prevention of lipopolysaccharide-induced intussusception in mice by the COX2 inhibitor rofecoxib.

Authors:  Mahmoud Badriyyah; Haggi Mazeh; Stefan Brocke; Venera Osmanova; Herbert R Freund; Menachem Hanani
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

Review 8.  Mechanisms of smooth muscle responses to inflammation.

Authors:  T Shea-Donohue; L Notari; R Sun; A Zhao
Journal:  Neurogastroenterol Motil       Date:  2012-09       Impact factor: 3.598

9.  Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.

Authors:  Wenhui Hu; Sunila Mahavadi; Fang Li; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-24       Impact factor: 4.249

10.  Diminished functional association between proximal and distal gastric motility in critically ill patients.

Authors:  Nam Q Nguyen; Robert J Fraser; Laura K Bryant; Marianne Chapman; Richard H Holloway
Journal:  Intensive Care Med       Date:  2008-02-23       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.